Skip to content

BillionToOne, Inc. BLLN Stock-Based Comp

Stock-Based Comp at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$31.7M-3.4%
Illumina logo
IlluminaILMN
$60M-17.8%
Guardant Health logo
Guardant HealthGH
$47.61M+26.1%
Natera, Inc. logo
Natera, Inc.NTRA
$95.11M+22.2%
NeoGenomics logo
NeoGenomicsNEO
$9.64M-10.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$16.04M-24.3%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.96B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's stock-based comp?
BillionToOne, Inc. (BLLN) reported stock-based comp of $6.51M in Q1 2026.
How has BillionToOne, Inc. 's stock-based comp changed year-over-year?
BillionToOne, Inc. 's stock-based comp increased by 174.2% year-over-year, from $2.37M to $6.51M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.